|
1
|
Smittenaar CR, Petersen KA, Stewart K and
Moitt N: Cancer incidence and mortality projections in the UK until
2035. Br J Cancer. 115:1147–1155. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Taib BG, Oakley J, Dailey Y, Hodge I,
Wright P, du Plessis R, Rylands J, Taylor-Robinson D, Povall S,
Schache A, et al: Socioeconomic deprivation and the burden of head
and neck cancer-regional variations of incidence and mortality in
mersey-side and cheshire, North West, England. Clin Otolaryngol.
43:846–853. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brocklehurst P, Kujan O, O'Malley LA,
Ogden G, Shepherd S and Glenny AM: Screening programmes for the
early detection and prevention of oral cancer. Cochrane Database
Syst Rev. 19:CD0041502013.
|
|
4
|
van der Waal I: Are we able to reduce the
mortality and morbidity of oral cancer; some considerations. Med
Oral Patol Oral Cir Bucal. 18:e33–e37. 2013. View Article : Google Scholar :
|
|
5
|
Friedrich RE: Delay in diagnosis and
referral patterns of 646 patients with oral and maxillofacial
cancer: A report from a single institution in Hamburg, Germany.
Anticancer Res. 30:1833–1836. 2010.PubMed/NCBI
|
|
6
|
Sherratt FC, Marcus MW, Robinson J and
Field JK: Utilizing lung cancer risk prediction models to promote
smoking cessation: Two randomized controlled trials. Am J Health
Promot. 32:1196–1205. 2018. View Article : Google Scholar
|
|
7
|
World Health Organisation: Guide to cancer
early diagnosis. 2017
|
|
8
|
Pfeiffer RM, Park Y, Kreimer AR, Lacey JV
Jr, Pee D, Greenlee RT, Buys SS, Hollenbeck A, Rosner B, Gail MH
and Hartge P: Risk prediction for breast, endometrial, and ovarian
cancer in white women aged 50 year or older: Derivation and
validation from population-based cohort studies. PLoS Med.
10:e10014922013. View Article : Google Scholar
|
|
9
|
Tammemagi CM, Pinsky PF, Caporaso NE,
Kvale PA, Hocking WG, Church TR, Riley TL, Commins J, Oken MM, Berg
CD and Prorok PC: Lung cancer risk prediction: Prostate, lung,
colorectal and ovarian cancer screening trial models and
validation. J Natl Cancer Inst. 103:1058–1068. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marcus MW, Chen Y, Raji OY, Duffy SW and
Field JK: LLPi: Liverpool lung project risk prediction model for
lung cancer incidence. Cancer Prev Res (Phila). 8:570–575. 2015.
View Article : Google Scholar
|
|
11
|
Ten Haaf K, Jeon J, Tammemägi MC, Han SS,
Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW and
Meza R: Risk prediction models for selection of lung cancer
screening candidates: A retrospective validation study. PLoS Med.
14:e10022772017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tammemagi MC, Schmidt H, Martel S,
McWilliams A, Goffin JR, Johnston MR, Nicholas G, Tremblay A,
Bhatia R, Liu G, et al: Participant selection for lung cancer
screening by risk modelling [the Pan-Canadian Early Detection of
Lung Cancer (PanCan) study]: A single-arm, prospective study.
Lancet Oncol. 18:1523–1531. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Collins GS, Reitsma JB, Altman DG and
Moons KG: Transparent reporting of a multivariable prediction model
for individual prognosis or diagnosis (TRIPOD): The TRIPOD
statement. Br J Cancer. 112:251–259. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
UK Biobank: Protocol for a large-scale
prospective epidemiological resource. 2007.
|
|
15
|
Public Health England (PHE): National
Cancer Registration and Analysis Service. https://www.gov.uk/guidance/national-cancer-regis-tration-and-analysis-service-ncrasuri.
Accessed November 3, 2016.
|
|
16
|
World Health Organisation (WHO):
International statistical classification of diseases and related
health problems, 10th revision (ICD-10). 2. 5th edition. WHO;
Geneva: 2016
|
|
17
|
Hashim D, Genden E, Posner M, Hashibe M
and Boffetta P: Head and neck cancer prevention: From primary
prevention to impact of clinicians on reducing burden. Ann Oncol.
30:744–756. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hashibe M, Brennan P, Benhamou S,
Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova
E, Fernandez L, et al: Alcohol drinking in never users of tobacco,
cigarette smoking in never drinkers, and the risk of head and neck
cancer: Pooled analysis in the international head and neck cancer
epidemiology consortium. J Natl Cancer Inst. 99:777–789. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hashibe M, Brennan P, Chuang SC, Boccia S,
Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova
E, et al: Interaction between tobacco and alcohol use and the risk
of head and neck cancer: Pooled analysis in the international head
and neck cancer epidemiology consortium. Cancer Epidemiol
Biomarkers Prev. 18:541–550. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hashibe M, Hunt J, Wei M, Buys S, Gren L
and Lee YC: Tobacco, alcohol, body mass index, physical activity,
and the risk of head and neck cancer in the prostate, lung,
colorectal, and ovarian (PLCO) cohort. Head Neck. 35:914–922. 2013.
View Article : Google Scholar
|
|
21
|
Shaw R and Beasley N: Aetiology and risk
factors for head and neck cancer: United Kingdom national
multidisciplinary guide-lines. J Laryngol Otol. 130(Suppl 2):
S9–S12. 2016. View Article : Google Scholar :
|
|
22
|
D'Souza G, McNeel TS and Fakhry C:
Understanding personal risk of oropharyngeal cancer: Risk-groups
for oncogenic oral HPV infection and oropharyngeal cancer. Ann
Oncol. 28:3065–3069. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Heck JE, Berthiller J, Vaccarella S, Winn
DM, Smith EM, Shan'gina O, Schwartz SM, Purdue MP, Pilarska A,
Eluf-Neto J, et al: Sexual behaviours and the risk of head and neck
cancers: A pooled analysis in the international head and neck
cancer epidemiology (INHANCE) consortium. Int J Epidemiol.
39:166–181. 2010. View Article : Google Scholar :
|
|
24
|
Heus P, Damen JAAG, Pajouheshnia R,
Scholten RJPM, Reitsma JB, Collins GS, Altman DG, Moons KGM and
Hooft L: Poor reporting of multivariable prediction model studies:
Towards a targeted implementation strategy of the TRIPOD statement.
BMC Med. 16:1202018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moons KG, Kengne AP, Grobbee DE, Royston
P, Vergouwe Y, Altman DG and Woodward M: Risk prediction models:
II. External validation, model updating, and impact assessment.
Heart. 98:691–698. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Riley RD, Ensor J, Snell KI, Debray TP,
Altman DG, Moons KG and Collins GS: External validation of clinical
prediction models using big datasets from e-health records or IPD
meta-analysis: Opportunities and challenges. BMJ. 353:i31402016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McCarthy CE, Field JK, Rajlawat BP, Field
AE and Marcus MW: Trends and regional variation in the incidence of
head and neck cancers in England: 2002 to 2011. Int J Oncol.
47:204–210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Steyerberg EW, Vickers AJ, Cook NR, Gerds
T, Gonen M, Obuchowski N, Pencina MJ and Kattan MW: Assessing the
performance of prediction models: A framework for traditional and
novel measures. Epidemiology. 21:128–138. 2010. View Article : Google Scholar
|
|
29
|
Collins GS, Ogundimu EO, Cook JA, Manach
YL and Altman DG: Quantifying the impact of different approaches
for handling continuous predictors on the performance of a
prog-nostic model. Stat Med. 35:4124–4135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Townsend P: Deprivation. J Soc Policy.
16:125–146. 1987. View Article : Google Scholar
|
|
31
|
NHS: Why 5 a day? 2018, https://www.nhs.uk/live-well/eat-well/why-5-a-day/uri.
Accessed October 8, 2018.
|
|
32
|
NHS: Physical activity guidelines for
older adults. 2018, https://www.nhs.uk/live-well/exercise/physical-activity-guidelines-older-adults/uri.
Accessed October 8, 2019.
|
|
33
|
Little RJB and Rubin DB: Statistical
analysis with missing data. 2nd edition. John Wiley & Sons,
Inc; Hoboken: 2014
|
|
34
|
Heinze G, Wallisch C and Dunkler D:
Variable selection-A review and recommendations for the practicing
statistician. Biom J. 60:431–449. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hosmer DW and Lemeshow S: Applied logistic
regression. John Wiley & Sons, Inc; New York, NY: 1989
|
|
36
|
Steyerberg EW, Harrell FE Jr, Borsboom GJ,
Eijkemans MJ, Vergouwe Y and Habbema JD: Internal validation of
predictive models: Efficiency of some procedures for logistic
regression analysis. J Clin Epidemiol. 54:774–781. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Van Calster B, Nieboer D, Vergouwe Y, De
Cock B, Pencina MJ and Steyerberg EW: A calibration hierarchy for
risk models was defined: From utopia to empirical data. J Clin
Epidemiol. 74:167–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Smith GC, Seaman SR, Wood AM, Royston P
and White IR: Correcting for optimistic prediction in small data
sets. Am J Epidemiol. 180:318–324. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
van der Ploeg T, Austin PC and Steyerberg
EW: Modern model-ling techniques are data hungry: A simulation
study for predicting dichotomous endpoints. BMC Med Res Methodol.
14:1372014. View Article : Google Scholar
|
|
40
|
Lee YA, Al-Temimi M, Ying J, Muscat J,
Olshan AF, Zevallos JP, Winn DM, Li G, Sturgis EM, Morgenstern H,
et al: Head and neck cancer risk prediction models for the US
population from the INHANCE consortium. Am J Epidemiol.
189:3302020. View Article : Google Scholar
|
|
41
|
Gail MH, Brinton LA, Byar DP, Corle DK,
Green SB, Schairer C and Mulvihill JJ: Projecting individualized
probabilities of developing breast cancer for white females who are
being examined annually. J Natl Cancer Inst. 81:1879–1886. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chawla NV and Davis DA: Bringing big data
to personalized healthcare: A patient-centered framework. J Gen
Intern Med. 28(Suppl 3): S660–S665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Field JK, Duffy SW, Baldwin DR, Brain KE,
Devaraj A, Eisen T, Green BA, Holemans JA, Kavanagh T, Kerr KM, et
al: The UK lung cancer screening trial: A pilot randomised
controlled trial of low-dose computed tomography screening for the
early detection of lung cancer. Health Technol Assess. 20:1–146.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Winn DM, Lee YC, Hashibe M and Boffetta P;
INHANCE consortium: The INHANCE consortium: Toward a better
under-standing of the causes and mechanisms of head and neck
cancer. Oral Dis. 21:685–693. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Beynon RA, Lang S, Schimansky S, Penfold
CM, Waylen A, Thomas SJ, Pawlita M, Waterboer T, Martin RM, May M
and Ness AR: Tobacco smoking and alcohol drinking at diagnosis of
head and neck cancer and all-cause mortality: Results from head and
neck 5000, a prospective observational cohort of people with head
and neck cancer. Int J Cancer. 143:1114–1127. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chuang SC, Jenab M, Heck JE, Bosetti C,
Talamini R, Matsuo K, Castellsague X, Franceschi S, Herrero R, Winn
DM, et al: Diet and the risk of head and neck cancer: A pooled
analysis in the INHANCE consortium. Cancer Causes Control.
23:69–88. 2012. View Article : Google Scholar
|
|
47
|
Ziech D, Franco R, Pappa A and
Panayiotidis MI: Reactive oxygen species (ROS)-induced genetic and
epigenetic alterations in human carcinogenesis. Mutat Res.
711:167–173. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Choudhari SK, Chaudhary M, Gadbail AR,
Sharma A and Tekade S: Oxidative and antioxidative mechanisms in
oral cancer and precancer: A review. Oral Oncol. 50:10–18. 2014.
View Article : Google Scholar
|
|
49
|
Gaudet MM, Olshan AF, Chuang SC,
Berthiller J, Zhang ZF, Lissowska J, Zaridze D, Winn DM, Wei Q,
Talamini R, et al: Body mass index and risk of head and neck cancer
in a pooled analysis of case-control studies in the international
head and neck cancer epidemiology (INHANCE) consortium. Int J
Epidemiol. 39:1091–1102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bhaskaran K, Douglas I, Forbes H,
dos-Santos-Silva I, Leon DA and Smeeth L: Body-mass index and risk
of 22 specific cancers: A population-based cohort study of 5.24
million UK adults. Lancet. 384:755–765. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mizoue T, Kasai H, Kubo T and Tokunaga S:
Leanness, smoking, and enhanced oxidative DNA damage. Cancer
Epidemiol Biomarkers Prev. 15:582–585. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wu LL, Chiou CC, Chang PY and Wu JT:
Urinary 8-OHdG: A marker of oxidative stress to DNA and a risk
factor for cancer, atherosclerosis and diabetics. Clin Chim Acta.
339:1–9. 2004. View Article : Google Scholar
|
|
53
|
Radoi L and Luce D: A review of risk
factors for oral cavity cancer: The importance of a standardized
case definition. Community Dent Oral Epidemiol. 41:97–109. e78–e91.
2013. View Article : Google Scholar
|
|
54
|
International Agency for Research on
Cancer (IARC): Reducing social inequalities in cancer: Evidence and
priorities for research. (IARC Scientific Publication No. 168).
Vaccarella S, Lortet-Tieulent J, Saracci R, Conway DI, Straif K and
Wild CP: IARC; Lyon, France: 2019
|
|
55
|
Faculty of general dental practice (UK):
Standards in Dentistry. 2018.
|
|
56
|
Achalli S, Madi M, Babu SG, Shetty SR,
Kumari S and Bhat S: Sialic acid as a biomarker of oral potentially
malignant disorders and oral cancer. Indian J Dent Res. 28:395–399.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Kallalli BN, Rawson K, Muzammil, Singh A,
Awati MA and Shivhare P: Lactate dehydrogenase as a biomarker in
oral cancer and oral submucous fibrosis. J Oral Pathol Med.
45:687–690. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Rock LD, Rosin MP, Zhang L, Chan B,
Shariati B and Laronde DM: Characterization of epithelial oral
dysplasia in non-smokers: First steps towards precision medicine.
Oral Oncol. 78:119–125. 2018. View Article : Google Scholar : PubMed/NCBI
|
